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Abstract
Confocal endomicroscopy is a powerful tool for in vivo real-time imaging at cellular
resolution inside a living body without tissue resection. Microscopic fluorescence
lifetime measurement can provide information about localized biochemical
conditions such as pH and the concentrations of oxygen and calcium. We
hypothesized that combining these techniques could assist accurate cancer
discrimination by providing both biochemical and morphological information. We
designed a dual-mode experimental setup for confocal endomicroscopic imaging and
fluorescence lifetime measurement and applied it to a mouse xenograft model of
activated human pancreatic cancer generated by subcutaneous injection of AsPC-1
tumor cells. Using this method with pH-sensitive sodium fluorescein injection, we
demonstrated discrimination between normal and cancerous tissues in a livingmouse.
With further development, this method may be useful for clinical cancer detection.
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1. Introduction
There has been a growing interest in diagnosing cancer without tissue resection
using a minimally invasive and fast approach that can replace immunohistochemi-
cal staining [1, 2, 3, 4]. Confocal endomicroscopy is a FDA-approved diagnostic
tool that enables the minimally invasive discrimination of abnormal lesions from
normal tissue surfaces inside a living body by high-resolution cellular imaging.
This technique has the advantage that optical biopsy images are displayed in real-
time to assist the physician in making immediate patient management decisions.
Many studies have demonstrated the use of confocal endomicroscopy for cancer
detection in various bodily regions, including stomach, pancreas, colon, alveoli,
bladder, and others [5, 6, 7, 8, 9, 10]. Despite its powerful advantages, several
issues have prevented confocal endomicroscopy from becoming widely accepted in
clinical use [11]. In particular, diagnostic efficacy is the most important area in
which its reliability has not yet been adequately validated.
The fluorescence lifetime of a molecule is the average time that it spends in the
excited state after absorbing extremely short pulsed laser energy [12]. Molecular
fluorescence lifetime is not dependent on laser power, the concentration of the
molecule, or photo-bleaching, but varies only due to the influence of the local
biochemical conditions on energy transfer. Therefore, fluorescence lifetime can be
used as an indicator of local biochemical conditions such as pH, the concentrations
of oxygen and calcium, and other factors [12, 13, 14, 15]. Various fluorescence
dyes have been used for in vivo and ex vivo studies of local biochemical conditions
to identify abnormal cells or tissues [12]. To avoid side effects of fluorescence
dyes, auto-fluorescence naturally emitted by endogenous fluorophores in living
tissues can also be applied for fluorescence lifetime measurements [16]. Certain
cancer-related auto-fluorescent molecules such as nicotinamide adenine dinucleo-
tide, flavin, and collagen may have altered fluorescence lifetimes due to local
perturbations in oxygen concentration and pH. Thus, fluorescent lifetime
measurement of auto-fluorescent molecules might present a foundation for the
detection of abnormal tissues. The functional information that can be obtained by
fluorescence lifetime measurements may help to make confocal endomicroscopy a
reliable diagnostic tool for cancer detection.
In this study, we designed a dual-mode experimental setup for confocal
endomicroscopic imaging and fluorescence lifetime measurement. A commercially
available confocal endomicroscope (Cellvizio, Mauna Kea Technologies, Paris,
France) and fluorescence lifetime spectrometer (FluoTime 300, PicoQuant, Berlin,
Germany) were linked to the same optical mini-probe (GastroFlex UHD, Mauna
Kea Technologies, Paris, France). To evaluate the effectiveness of this approach
for cancer detection, we subcutaneously injected AsPC-1 activated human
pancreatic cancer cells into a living mouse, followed by intravenous injection of
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sodium fluorescein. Sodium fluorescein is a FDA-approved fluorophore widely
used as a diagnostic tool in the fields of ophthalmology and cancer detection. The
fluorescence lifetime of sodium fluorescein depends on the local pH [17]. Since pH
differs between abnormal and normal tissues, they can be differentiated by
measuring the fluorescence lifetime of pH-sensitive sodium fluorescein. We
morphologically discriminated abnormal and normal tissues by confocal
endomicroscopic imaging, and then functionally discriminated them by measuring
the fluorescence lifetime of injected sodium fluorescein.
2. Material and methods
2.1. Experimental setup
An experimental concept for the analysis of local biochemical conditions by
fluorescence lifetime measurement combined with confocal endomicroscopy is
presented in Fig. 1. Nude mouse activated human pancreas cancer AsPC-1 was
prepared for the animal test. Sodium fluorescein was used as a fluorescent probe
and intravenously injected into the mouse model. Then, the living mouse tissues
were morphologically screened by confocal endomicroscopy. When tissues with an
unusual morphology were identified by confocal imaging, the distal end of the
probe was fixed using a holding jig and the opposite end of the probe was removed
from confocal endomicroscopy and connected to the interface module for
measurement of fluorescence lifetime. The fluorescence lifetime of sodium
fluorescein diffused in that area was measured by fluorescence lifetime
spectroscopy. The same process was applied for normal tissue.
[(Fig._1)TD$FIG]
Fig. 1. Experimental concept: (1) Preparation of nude mouse activated human pancreas cancer AsPC-1
(2) Injection of sodium fluorescein (Intravenous (IV) injection) (3) Getting morphologic information by
confocal endomicroscopy (4) Measurement of fluorescence lifetime by fluorescence lifetime
spectroscopy.
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The dual-mode experimental setup for confocal fluorescence endomicroscopic
imaging and fluorescence lifetime measurement was shown in Fig. 2. After
generating the mouse model, it was morphologically analyzed by confocal
endomicroscopy with confocal mini-probe consisted of about 30,000 optical fibers.
The diameter and working distance of used mini-probe was about 2.8 mm and
55–66 um, respectively. The confocal endomicroscopy provided the image as a
circular pattern. The diameter for maximum field of view was 600 um and the
lateral resolution was 3.5 um. The used light source of the confocal
endomicroscopy was continuous laser with a center wavelength (λc) of 488 nm
and the average incident power (Pavg) of 1 mW. After morphological analysis, the
same mini-probe used for confocal endomicroscopy was applied as a probe for
fluorescence lifetime measurements. The fluorescence lifetime of the same region
examined by confocal imaging could be measured by fixing the distal end of the
mini-probe and moving its opposite end to the specially designed optical interface
module. The optical interface module was realized by confocal point measurement
setup to perform confocal fluorescence lifetime measurement. For the light source
of fluorescence lifetime spectrometer, a diode pulse laser with a center wavelength
of 479 nm, the average incident power (Pavg) of 2 mW, the pulse duration (frr) of
10 MHz, and the pulse width (△λ) of 30 ps was used. The diode pulse laser was
passed through a short pass filter with cutoff wavelength of 500 nm and reflected
by a dichroic mirror and injected into the region of interest of the living mouse
after passing through an objective lens and the mini-probe. The fluorescence pulse
signals from fluorescein inside the mouse were transmitted through the same
components in the reverse direction and passed through the dichroic mirror, a long
pass filter with cutoff wavelength of 500 nm, and collimating lens. Finally, the
[(Fig._2)TD$FIG]
Fig. 2. Dual-mode experimental setup for confocal fluorescence endomicroscopic imaging and
fluorescence lifetime measurement.
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fluorescence pulse signals went to the optical fiber of the fluorescence lifetime
spectrometer.
2.2. Preparation of animal model
In vivo tumor xenograft experiments were conducted using 6-week-old male
athymic nude mouse (BALB/c-nu) purchased from Central Lab. Animal Inc.
(Seoul, South Korea). As shown in Fig. 3, tumors were implanted into the
abdomens of the mouse by the subcutaneous injection of 1 × 107 AsPC-1 human
pancreas cancer cells in 100 μL of serum-free Dulbecco’s modified Eagle’s
medium (Gibco®, Thermo Fisher Scientific, Waltham, MA). The mouse was
maintained in a laminar air flow cabinet under specific pathogen-free conditions.
Ethical approval was received and all facilities were approved by the Association
of Assessment and Accreditation of Laboratory Animal Care, and all animal
experiments were conducted under the institutional guidelines established by the
Animal Core Facility at The Catholic University of Korea. This animal care and
use protocol was reviewed and approved by the IACUC in School of Medicine,
The Catholic University of Korea (CUMC-2015-0189-02). When the tumor size
reached 100–150 mm3, fluorescein was injected intravenously via the tail vein.
Sodium fluorescein (100 mg/mL, 10%;[w/v], Novartis, Basel, Switzerland) was
diluted to a final concentration of 0.01% (w/v) with phosphate buffered saline, and
200 μl of the diluted solution was injected into the mouse tail vein.
3. Results and discussion
To detect local pH variation between abnormal and normal tissues in a living
mouse, sodium fluorescein was injected as described above, and the abnormal and
normal tissues of the mouse were screened using standard confocal endomicro-
scopy. It has been demonstrated that morphological changes such as fibrosis often
occur in tissues associated with neoplasia [11]. For confocal endomicroscopy,
there is a library of case studies and atlases of normal and disease states available
online, which we used for reference [18]. Through confocal fluorescence
endomicroscopy analysis, we identified morphological differences between the
[(Fig._3)TD$FIG]
Fig. 3. Formation of human pancreatic cancer in a mouse model following subcutaneous injection of
AsPC-1 cells.
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cancerous and normal tissues as shown in Fig. 4. Confocal fluorescence images of
normal mouse abdominal subcutaneous tissue and the same tissue containing
structures associated with the pancreatic cancer structures are shown in Fig. 4(a)
and (b), respectively. Here, the normal mouse abdominal subcutaneous tissue
architecture is visualized well on a cellular level while pancreatic cancer tissue is
not clear [19].
To discriminate abnormal tissues from normal tissues, the fluorescence lifetime of
injected pH-sensitive sodium fluorescein was measured by fluorescence lifetime
spectroscopy. Fluorescence curves after excitation by laser pulses were measured
and plotted as shown in Fig. 5. Since the fluorescence lifetime of sodium
fluorescein decreased according to the drop in pH, the widths of the fluorescence
curves were shorter in abnormal than in normal tissue, indicating that the pH value
of abnormal tissue was lower than that of normal tissue [17]. Curve fitting and
calculation of fluorescence lifetimes were performed with FluoFit software
(PicoQuant). Fluorescence curves were measured for three different areas in each
of the normal and abnormal tissues. The photon numbers used to plot the
fluorescence curves were more than 100,000. The measured fluorescence lifetimes
of sodium fluorescein inside the normal and abnormal tissues were 3.69 ∼ 3.81 and
3.09 ∼ 3.44 ns, respectively. Since the measured fluorescence lifetimes for
abnormal tissues were well differentiated from those for normal tissues, the
fluorescence lifetime of sodium fluorescein could be used as an indicator to
increase the accuracy of cancer detection with confocal endomicroscopy.
4. Conclusions
In this paper, we have demonstrated the application of fluorescence lifetime
measurement combined with confocal endomicroscopy for the analysis of tissue
biochemistry in a living mouse xenograft model of activated human pancreatic
cancer. The abnormal and normal tissues were morphologically analyzed by
confocal microendoscopic imaging, then we evaluated the possibility of
[(Fig._4)TD$FIG]
(a) (b)
Fig. 4. Confocal fluorescence imaging of (a) normal and (b) pancreatic cancer infiltrated mouse
abdominal subcutaneous tissue.
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discriminating between them based on the fluorescence lifetime of sodium
fluorescein, which is mainly influenced by the local tissue pH. We successfully
discriminated the cancerous and normal tissues, indicating that this method may
enable early cancer detection without tissue resection. Subsequent studies are
warranted to assess the utility of applying this technique for fluorescent lifetime
measurements of endogenous autofluorescent materials or other biocompatible
fluorescent materials that are sensitive to changes in parameters such as pH,
oxygen concentration, and temperature in the cancer tissue environment.
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